Rp114.90
+
Rp0.30 (0.26%)
End-of-day quote: 05/17/2024
BSE:542934
Chandra Bhagat Pharma Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | NYSE | Outperform | $770.00 | $636.99 | 0.00% | 9 | $693.31B |
| JNJ | Johnson & Johnson | NYSE | Outperform | $154.64 | $174.55 | 0.00% | 3 | $372.17B |
| MRK | Merck | NYSE | Outperform | $131.19 | $130.51 | 0.00% | 11 | $332.28B |
| ABBV | AbbVie | NYSE | Outperform | $166.42 | $178.42 | 0.00% | 11 | $293.88B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.10 | £165.99 | 0.00% | 16 | £187.73B |
| ROG | Roche Holding | SWX | Hold | CHF237.10 | CHF307.83 | 0.00% | 9 | CHF191.28B |
| NOVN | Novartis | SWX | Hold | CHF93.37 | CHF105.00 | 0.00% | 9 | CHF190.51B |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| SAN | Sanofi | ENXTPA | Outperform | 89.17€ | 102.80€ | 0.00% | 9 | 111.47€B |
| GSK | GSK | LSE | Outperform | £17.75 | £17.30 | 0.00% | 12 | £72.39B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.03 | $58.15 | 0.00% | 10 | $89.25B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $67.72 | $87.82 | 0.00% | 14 | $84.37B |
| BIIB | Biogen | NasdaqGS | Outperform | $230.57 | $299.62 | 0.00% | 13 | $33.57B |
| VAISHALI | Vaishali Pharma | NSEI | - | Rp158.30 | Rp0.00 | 0.00% | 0 | Rp1.74B |
| 542724 | Earum Pharmaceuticals | BSE | - | 1.72 | 0.00 | 0.00% | 0 | 425.03M |
